These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 16353278)

  • 1. Cyclooxygenase-1 and cyclooxygenase-2 inhibition of novel 1,2-disubstituted imidazoles.
    Handler N; Jaeger W; Kuen-Krismer B; Erker T
    Arch Pharm (Weinheim); 2005 Dec; 338(12):602-4. PubMed ID: 16353278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 2,3-diaryl-1,3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Zarghi A; Najafnia L; Daraee B; Dadrass OG; Hedayati M
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5634-7. PubMed ID: 17822894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors.
    Cheng H; Lundy DeMello KM; Li J; Sakya SM; Ando K; Kawamura K; Kato T; Rafka RJ; Jaynes BH; Ziegler CB; Stevens R; Lund LA; Mann DW; Kilroy C; Haven ML; Nimz EL; Dutra JK; Li C; Minich ML; Kolosko NL; Petras C; Silvia AM; Seibel SB
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2076-80. PubMed ID: 16464588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and screening of cyclooxygenase inhibitory activity of some 1,3-dioxoisoindoline derivatives.
    Cizmeciolu M; Pabuguoglu V; Ballar P; Pabuççuoğlu A; Soyer Z
    Arzneimittelforschung; 2011; 61(3):186-90. PubMed ID: 21528644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationship of novel, highly potent metharyl and methcycloalkyl cyclooxygenase-2 (COX-2) selective inhibitors.
    Khanapure SP; Garvey DS; Young DV; Ezawa M; Earl RA; Gaston RD; Fang X; Murty M; Martino A; Shumway M; Trocha M; Marek P; Tam SW; Janero DR; Letts LG
    J Med Chem; 2003 Dec; 46(25):5484-504. PubMed ID: 14640557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of new 2,3-diarylquinoline derivatives as selective cyclooxygenase-2 inhibitors.
    Ghodsi R; Zarghi A; Daraei B; Hedayati M
    Bioorg Med Chem; 2010 Feb; 18(3):1029-33. PubMed ID: 20061161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib: reversal cyclooxygenase-2 selectivity by sulfonamide group removal.
    Di Nunno L; Vitale P; Scilimati A; Tacconelli S; Patrignani P
    J Med Chem; 2004 Sep; 47(20):4881-90. PubMed ID: 15369392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors.
    Ranatunge RR; Earl RA; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schwalb DJ; Young DV; Zemtseva IS
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6049-52. PubMed ID: 15546727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of new rofecoxib analogs as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of the methanesulfonyl pharmacophore by a N-acetylsulfonamido bioisostere.
    Zarghi A; Rao PN; Knaus EE
    J Pharm Pharm Sci; 2007; 10(2):159-67. PubMed ID: 17706175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of acyclic triaryl olefins: a new class of potent and selective cyclooxygenase-2 (COX-2) inhibitors.
    Uddin MJ; Rao PN; Knaus EE
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1953-6. PubMed ID: 15050635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of cyclooxygenase isoenzymes in the cat by the NSAID robenacoxib.
    Giraudel JM; Toutain PL; King JN; Lees P
    J Vet Pharmacol Ther; 2009 Feb; 32(1):31-40. PubMed ID: 19161453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of (E)-1,1,2-triarylethenes: novel inhibitors of the cyclooxygenase-2 (COX-2) isozyme.
    Uddin MJ; Rao PN; McDonald R; Knaus EE
    Bioorg Med Chem Lett; 2005 Jan; 15(2):439-42. PubMed ID: 15603969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of linear 1-(4-, 3- or 2-methylsulfonylphenyl)-2-phenylacetylenes: a novel class of cyclooxygenase-2 inhibitors.
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2005 Dec; 13(23):6425-34. PubMed ID: 16099663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of methanesulfonamide analogues of rofecoxib: Replacement of methanesulfonyl by methanesulfonamido decreases cyclooxygenase-2 selectivity.
    Zarghi A; Praveen Rao PN; Knaus EE
    Bioorg Med Chem; 2007 Jan; 15(2):1056-61. PubMed ID: 17067801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors.
    Zarghi A; Ghodsi R
    Bioorg Med Chem; 2010 Aug; 18(16):5855-60. PubMed ID: 20650641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors.
    Zarghi A; Ghodsi R; Azizi E; Daraie B; Hedayati M; Dadrass OG
    Bioorg Med Chem; 2009 Jul; 17(14):5312-7. PubMed ID: 19560931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and cyclooxygenase-2 inhibiting property of 1,5-diarylpyrazoles with substituted benzenesulfonamide moiety as pharmacophore: Preparation of sodium salt for injectable formulation.
    Pal M; Madan M; Padakanti S; Pattabiraman VR; Kalleda S; Vanguri A; Mullangi R; Mamidi NV; Casturi SR; Malde A; Gopalakrishnan B; Yeleswarapu KR
    J Med Chem; 2003 Sep; 46(19):3975-84. PubMed ID: 12954051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and selective cyclooxygenase-2 inhibitory activity of a series of novel, nitric oxide donor-containing pyrazoles.
    Ranatunge RR; Augustyniak M; Bandarage UK; Earl RA; Ellis JL; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schroeder JD; Shumway MJ; Tam SW; Trocha AM; Young DV
    J Med Chem; 2004 Apr; 47(9):2180-93. PubMed ID: 15084117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 2,3-diarylpyrazines and quinoxalines as selective COX-2 inhibitors.
    Singh SK; Saibaba V; Ravikumar V; Rudrawar SV; Daga P; Rao CS; Akhila V; Hegde P; Rao YK
    Bioorg Med Chem; 2004 Apr; 12(8):1881-93. PubMed ID: 15051057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.